Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

The Peter MacCallum Cancer Centre

2 abstracts

Abstract
Primary overall survival analysis of the phase 3 randomized ZUMA‑7 study of axicabtagene ciloleucel versus standard‑of‑care therapy in relapsed/refractory large B-cell lymphoma.
Org: Vanderbilt University Cancer Center, University of Amsterdam, Stanford University School of Medicine, Washington University School of Medicine, Hematology Department, Institut Català d'Oncologia-Hospitalet,
Abstract
Glofitamab + Pola-R-CHP in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): Results from a phase Ib study.
Org: The Peter MacCallum Cancer Centre, Royal Melbourne Hospital, The University of Melbourne, Department of Internal Medicine III, University Hospital Ulm, Klinik für Innere Medizin I, Hämatologie, Onkologie und Stammzelltransplantation Centrum für Chronische Immundefizienz (CCI),